Literature DB >> 17565510

Lipids changes in liver cancer.

Jing-Ting Jiang1, Ning Xu, Xiao-Ying Zhang, Chang-Ping Wu.   

Abstract

Liver is one of the most important organs in energy metabolism. Most plasma apolipoproteins and endogenous lipids and lipoproteins are synthesized in the liver. It depends on the integrity of liver cellular function, which ensures homeostasis of lipid and lipoprotein metabolism. When liver cancer occurs, these processes are impaired and the plasma lipid and lipoprotein patterns may be changed. Liver cancer is the fifth common malignant tumor worldwide, and is closely related to the infections of hepatitis B virus (HBV) and hepatitis C virus (HCV). HBV and HCV infections are quite common in China and other Southeast Asian countries. In addition, liver cancer is often followed by a procession of chronic hepatitis or cirrhosis, so that hepatic function is damaged obviously on these bases, which may significantly influence lipid and lipoprotein metabolism in vivo. In this review we summarize the clinical significance of lipid and lipoprotein metabolism under liver cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565510      PMCID: PMC1879165          DOI: 10.1631/jzus.2007.B0398

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  118 in total

1.  Differential tissue-specific expression of human apoA-I and apoA-II.

Authors:  T L Eggerman; J M Hoeg; M S Meng; A Tombragel; D Bojanovski; H B Brewer
Journal:  J Lipid Res       Date:  1991-05       Impact factor: 5.922

2.  Lack of effect of acute alcohol ingestion on plasma lipids.

Authors:  S Booth; P M Clifton; P J Nestel
Journal:  Clin Chem       Date:  1991-09       Impact factor: 8.327

3.  Specific growth stimulation by linoleic acid in hepatoma cell lines transfected with the target protein of a liver carcinogen.

Authors:  T Keler; C S Barker; S Sorof
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

4.  Characterization of a human hepatic receptor for high density lipoproteins.

Authors:  J M Hoeg; S J Demosky; S B Edge; R E Gregg; J C Osborne; H B Brewer
Journal:  Arteriosclerosis       Date:  1985 May-Jun

5.  Effect of human mammary MX-1 tumor on plasma free fatty acids in fasted and fasted-refed nude mice.

Authors:  C Lin; W Blank; R L Ceriani; N Baker
Journal:  Lipids       Date:  1992-01       Impact factor: 1.880

6.  Selective killing of human cancer cells by polyunsaturated fatty acids.

Authors:  M E Bégin; U N Das; G Ells; D F Horrobin
Journal:  Prostaglandins Leukot Med       Date:  1985-08

7.  Eicosapentaenoic acid inhibits cell growth and triacylglycerol secretion in McA-RH7777 rat hepatoma cultures.

Authors:  J C Fox; R V Hay
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

8.  Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer.

Authors:  K Kumar; P Sachdanandam; R Arivazhagan
Journal:  Biochem Int       Date:  1991-02

9.  Growth inhibition of human hepatoma cells (HepG2) by polyunsaturated fatty acids. Protection by albumin and vitamin E.

Authors:  A T Høstmark; E Lystad
Journal:  Acta Physiol Scand       Date:  1992-01

10.  Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies.

Authors:  M R Law; S G Thompson
Journal:  Cancer Causes Control       Date:  1991-07       Impact factor: 2.506

View more
  28 in total

1.  Association of Antituberculosis Treatment and Lower Risk of Hyperlipidemia in Taiwanese Patients: A Population-Based Case-Control Study.

Authors:  Ying-Ray Lee; N I Tien; Cheng-Li Lin; Hsin-Yi Shen; DA-Tian Bau; Yun-Ping Lim
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

2.  Bioinformatic analysis of microRNA networks following the activation of the constitutive androstane receptor (CAR) in mouse liver.

Authors:  Ruixin Hao; Shengzhong Su; Yinan Wan; Frank Shen; Ben Niu; Denise M Coslo; Istvan Albert; Xing Han; Curtis J Omiecinski
Journal:  Biochim Biophys Acta       Date:  2016-04-11

3.  Stabilized oral nanostructured lipid carriers of Adefovir Dipivoxil as a potential liver targeting: Estimation of liver function panel and uptake following intravenous injection of radioiodinated indicator.

Authors:  Shady M Abd El-Halim; Ghada A Abdelbary; Maha M Amin; Mohamed Y Zakaria; Hesham A Shamsel-Din; Ahmed B Ibrahim
Journal:  Daru       Date:  2020-06-20       Impact factor: 3.117

4.  [(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinoma.

Authors:  Nicolas Salem; Yu Kuang; David Corn; Bernadette Erokwu; Jeffrey A Kolthammer; Haibin Tian; Chunying Wu; Fangjing Wang; Yanming Wang; Zhenghong Lee
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

Review 5.  The split personality of NKT cells in malignancy, autoimmune and allergic disorders.

Authors:  Jeff J Subleski; Qun Jiang; Jonathan M Weiss; Robert H Wiltrout
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

6.  Systemic transcriptome analysis of hepatocellular carcinoma.

Authors:  Cheng-Bo Yu; Li-Yao Zhu; Yu-Gang Wang; Fen Li; Xiao-Yu Zhang; Wei-Jie Dai
Journal:  Tumour Biol       Date:  2016-07-26

7.  An unannotated alpha/beta hydrolase superfamily member, ABHD6 differentially expressed among cancer cell lines.

Authors:  Fan Li; Xiangwei Fei; Jiaxi Xu; Chaoneng Ji
Journal:  Mol Biol Rep       Date:  2008-03-22       Impact factor: 2.316

8.  Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy.

Authors:  Xing-guo Zhang; Jing Miao; Min-wei Li; Sai-ping Jiang; Fu-qiang Hu; Yong-zhong Du
Journal:  J Zhejiang Univ Sci B       Date:  2008-06       Impact factor: 3.066

9.  Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).

Authors:  Susanne Strohmaier; Michael Edlinger; Jonas Manjer; Tanja Stocks; Tone Bjørge; Wegene Borena; Christel Häggström; Anders Engeland; Gabriele Nagel; Martin Almquist; Randi Selmer; Steinar Tretli; Hans Concin; Göran Hallmans; Håkan Jonsson; Pär Stattin; Hanno Ulmer
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Enhancing the utility of Proteomics Signature Profiling (PSP) with Pathway Derived Subnets (PDSs), performance analysis and specialised ontologies.

Authors:  Wilson Wen Bin Goh; Mengyuan Fan; Hong Sang Low; Marek Sergot; Limsoon Wong
Journal:  BMC Genomics       Date:  2013-01-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.